IDEXX Laboratories, Inc.
IDXX
$752.88
-$3.08-0.41%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 274.61M | 293.99M | 242.68M | 216.15M | 232.84M |
| Total Depreciation and Amortization | 36.63M | 35.77M | 34.06M | 33.71M | 34.13M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 111.05M | 19.84M | 21.91M | 20.91M | 10.47M |
| Change in Net Operating Assets | -19.95M | -163.86M | -60.69M | -8.74M | -57.37M |
| Cash from Operations | 402.34M | 185.74M | 237.96M | 262.03M | 220.08M |
| Capital Expenditure | -31.11M | -34.10M | -30.03M | -29.26M | -28.09M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 306.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.76M | 474.00K | 416.00K | -10.59M | 415.00K |
| Cash from Investing | -44.87M | -33.63M | -29.61M | -39.84M | -27.37M |
| Total Debt Issued | -124.00M | 259.50M | 69.50M | -- | -- |
| Total Debt Repaid | 0.00 | -103.39M | -- | 0.00 | -75.00M |
| Issuance of Common Stock | 50.97M | 17.33M | 7.19M | 13.26M | 5.00M |
| Repurchase of Common Stock | -240.28M | -339.08M | -407.01M | -246.04M | -220.98M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -313.31M | -165.63M | -330.32M | -232.78M | -290.98M |
| Foreign Exchange rate Adjustments | -587.00K | 14.14M | -2.33M | -9.77M | 5.31M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 43.57M | 624.00K | -124.30M | -20.37M | -92.95M |